BE637271A
(me)
|
1963-04-04 |
1900-01-01 |
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
WO1997038665A2
(en)
|
1996-04-03 |
1997-10-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6432947B1
(en)
|
1997-02-19 |
2002-08-13 |
Berlex Laboratories, Inc. |
N-heterocyclic derivatives as NOS inhibitors
|
BRPI9810945B8
(pt)
|
1997-06-27 |
2021-05-25 |
Abraxis Bioscience Inc |
formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
|
JP3711238B2
(ja)
|
1997-08-05 |
2005-11-02 |
ファイザー・プロダクツ・インク |
神経ペプチドY受容体アンタゴニストとしての4−アミノピロ−ル(3,2−d)ピリミジン
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
IL139811A0
(en)
|
1998-06-04 |
2002-02-10 |
Abbott Lab |
Cell adhesion-inhibiting antinflammatory compounds
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
EP1181296A1
(en)
|
1999-06-03 |
2002-02-27 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
ATE423120T1
(de)
|
2000-06-26 |
2009-03-15 |
Pfizer Prod Inc |
Pyrroloä2,3-düpyrimidin verbindungen als immunosuppressive wirkstoffe
|
CN1308324C
(zh)
|
2000-08-31 |
2007-04-04 |
弗·哈夫曼-拉罗切有限公司 |
作为α-1肾上腺素能拮抗剂的喹唑啉衍生物
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
WO2002057267A1
(en)
|
2000-12-01 |
2002-07-25 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
|
US20020182204A1
(en)
*
|
2001-03-23 |
2002-12-05 |
Marie-Christine Bissery |
Combination of a taxane and a cyclin-dependent kinase
|
KR101108722B1
(ko)
|
2002-01-07 |
2012-02-17 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
데아자퓨린 및 이의 용도
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
KR20050000544A
(ko)
|
2002-05-17 |
2005-01-05 |
아방티 파르마 소시에테 아노님 |
유방암 및 난소암의 보조 요법에서도세탁셀/독소루비신/사이클로포스파미드의 용도
|
ES2464157T3
(es)
|
2002-06-26 |
2014-05-30 |
Ono Pharmaceutical Co., Ltd. |
Remedios para enfermedades causadas por contracción o dilatación vascular
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
US20050288503A1
(en)
|
2002-09-06 |
2005-12-29 |
Adams Jerry L |
Novel compounds
|
WO2004043380A2
(en)
|
2002-11-08 |
2004-05-27 |
President And Fellows Of Harvard College |
Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
|
AU2003302657B8
(en)
|
2002-12-04 |
2009-12-03 |
Eisai R&D Management Co., Ltd. |
Fused 1,3-dihydroimidazole ring compounds
|
EP1444982A1
(de)
|
2003-02-06 |
2004-08-11 |
Merckle Gmbh |
Verwendung von Purinderivaten als selektive Kinase-Inhibitoren
|
EP1601357A4
(en)
|
2003-03-10 |
2007-10-03 |
Schering Corp |
HETEROCYCLIC KINASE INHIBITORS: METHOD OF USE AND SYNTHESIS
|
US20060128956A1
(en)
|
2003-04-21 |
2006-06-15 |
Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky |
(Purin-6-yl) amino acid and production method thereof
|
FR2856685B1
(fr)
|
2003-06-25 |
2005-09-23 |
Merck Sante Sas |
Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
TW200526626A
(en)
|
2003-09-13 |
2005-08-16 |
Astrazeneca Ab |
Chemical compounds
|
RU2006121990A
(ru)
|
2003-11-21 |
2007-12-27 |
Эррэй Биофарма Инк. (Us) |
Ингибиторы протеинкиназ акт
|
US7511159B2
(en)
|
2003-12-25 |
2009-03-31 |
Ono Pharmaceutical Co., Ltd. |
Azetidine ring compounds and drugs comprising the same
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
US7994172B2
(en)
|
2004-12-28 |
2011-08-09 |
Exelixis, Inc. |
[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
FR2880540B1
(fr)
|
2005-01-13 |
2008-07-11 |
Aventis Pharma Sa |
Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
|
FR2880626B1
(fr)
|
2005-01-13 |
2008-04-18 |
Aventis Pharma Sa |
Derives de la purine, compositions les contenant et utilisation
|
US7423043B2
(en)
|
2005-02-18 |
2008-09-09 |
Lexicon Pharmaceuticals, Inc. |
4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
|
US20060281768A1
(en)
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
EP1910358A2
(en)
|
2005-07-14 |
2008-04-16 |
Astellas Pharma Inc. |
Heterocyclic janus kinase 3 inhibitors
|
WO2007025090A2
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
|
CN101291659A
(zh)
|
2005-08-31 |
2008-10-22 |
阿布拉科斯生物科学有限公司 |
包含水难溶性药剂和抗微生物剂的组合物
|
NZ592132A
(en)
|
2005-08-31 |
2012-12-21 |
Abraxis Bioscience Llc |
Composition comprising nanoparticles of docitaxel and a citrate
|
US20070208053A1
(en)
|
2006-01-19 |
2007-09-06 |
Arnold Lee D |
Fused heterobicyclic kinase inhibitors
|
US20090082370A1
(en)
|
2006-04-25 |
2009-03-26 |
Neil Thomas Thompson |
Pharmaceutical Combinations of PK Inhibitors and Other Active Agents
|
EP2016077A2
(en)
|
2006-04-25 |
2009-01-21 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
DK3421471T3
(da)
|
2006-04-25 |
2021-06-14 |
Astex Therapeutics Ltd |
Purin- og deazapurinderivater som farmaceutiske forbindelser
|
EP2029592A1
(en)
|
2006-04-25 |
2009-03-04 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
US8828451B2
(en)
*
|
2006-10-04 |
2014-09-09 |
University Of South Florida |
Akt sensitization of cancer cells
|
WO2008079346A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
AR064415A1
(es)
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de pirrolo-piperidinas y purinas,composiciones farmaceuticas que los contienen y usos en trastornos y/o enfermedades mediadas por pka y pkb.
|
AR064416A1
(es)
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
MY150059A
(en)
*
|
2007-10-11 |
2013-11-29 |
Astrazeneca Ab |
Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
|
EP2694056B1
(en)
*
|
2011-04-01 |
2019-10-16 |
AstraZeneca AB |
Therapeutic treatment
|